| Patient access to biologic DMARDs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) may impact medication treatment effectiveness by lowering the odds of medication adherence. |
| A step-therapy approach to bDMARDs or tsDMARDs has an adverse impact on treatment effectiveness that might lead to higher healthcare resource use. |
| Payers might consider improving patient access to various bDMARDs and tsDMARDs to improve patient adherence and overall treatment effectiveness. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.